Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease.

Though it should be noted the lower quartile (<10 μg/mL) had a lower clinical response rate compared to higher quartile drug trough levels, although this did not reach statistical significance.

also in 111,027 other papers